You can now read 5 articles in a month for free on Read as much as you want anywhere and anytime for just 99¢.

Mass. Movers

Drug developer reports loss, debt facility


Infinity Pharmaceuticals cut its fourth-quarter net loss to $32.9 million, or 68 cents per share, compared with $46.9 million, or $1.15 per share, a year earlier. The Cambridge-based company said its full-year net loss was $126.7 million, or $2.64 per share, compared with $53.9 million, or $1.70, the previous year. It also said it entered into an agreement with affiliates of Deerfield Management Co., a health care investment organization and Infinity shareholder, to provide a $100 million debt facility.

Loading comments...

Wake up with today's top stories.

Want each day's news headlines delivered fresh to your
inbox every morning? Just connect with us
in one of the following ways:
Please enter a valid email will never post anything without asking.
Privacy Policy
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of